1. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- Author
-
Vincent J. Munster, Craig Martens, Kent D. Barbian, Victoria A. Avanzato, Francis X. Riedo, Seth D. Judson, Rhys Pryce, Sarah L. Anzick, Thomas A. Bowden, Brandi N. Williamson, Stephanie N. Seifert, Emmie de Wit, M. Jeremiah Matson, and Elizabeth R. Fischer
- Subjects
Chronic lymphocytic leukemia ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,Biology ,Antibodies, Viral ,Asymptomatic ,Article ,General Biochemistry, Genetics and Molecular Biology ,Hypogammaglobulinemia ,03 medical and health sciences ,0302 clinical medicine ,asymptometic ,medicine ,Humans ,within host evolution ,Respiratory Tract Infections ,030304 developmental biology ,Subgenomic mRNA ,Aged ,0303 health sciences ,SARS-CoV-2 ,RNA ,COVID-19 ,long-term shedding ,medicine.disease ,Virology ,Leukemia, Lymphocytic, Chronic, B-Cell ,immunocompromised ,medicine.anatomical_structure ,Common Variable Immunodeficiency ,convalescent plasma ,Vero cell ,chronic lymphocytic leukemia ,Female ,medicine.symptom ,infectious virus ,030217 neurology & neurosurgery ,Respiratory tract - Abstract
Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding was observed from the upper respiratory tract of a female immunocompromised individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia. Shedding of infectious SARS-CoV-2 was observed up to 70 days, and of genomic and subgenomic RNA up to 105 days, after initial diagnosis. The infection was not cleared after the first treatment with convalescent plasma, suggesting a limited effect on SARS-CoV-2 in the upper respiratory tract of this individual. Several weeks after a second convalescent plasma transfusion, SARS-CoV-2 RNA was no longer detected. We observed marked within-host genomic evolution of SARS-CoV-2 with continuous turnover of dominant viral variants. However, replication kinetics in Vero E6 cells and primary human alveolar epithelial tissues were not affected. Our data indicate that certain immunocompromised individuals may shed infectious virus longer than previously recognized. Detection of subgenomic RNA is recommended in persistently SARS-CoV-2-positive individuals as a proxy for shedding of infectious virus., Graphical Abstract, Highlights • Persistent SARS-CoV-2 infection and shedding in immunocompromised individual • Infectious SARS-CoV-2 isolated up to 70 days after diagnosis • Observed within-host genetic variation with continuous turnover of viral variants • SARS-CoV-2 isolates from the individual do not display altered replication, This case study describes a female immunocompromised individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia who became persistently infected with SARS-CoV-2. Although asymptomatic throughout the course of infection, she demonstrated prolonged shedding of infectious SARS-CoV-2 virus and RNA. This study demonstrates that certain individuals may remain infectious for prolonged periods of time and highlights the need for further studies to understand risk factors for prolonged infectious SARS-CoV-2 shedding.
- Published
- 2020
- Full Text
- View/download PDF